EMVision Medical Devices Ltd (EMV.AX)
AUD 1.89
(-0.53%)
AUD 1.89
(-0.53%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.99 Million | 834.15 Thousand | -3.78 Million | -4.49 Million | -3.25 Million | -2.21 Million |
| Net Income | -2.72 Million | -3.87 Million | -6.1 Million | -8.39 Million | -3.47 Million | -2.95 Million |
| Depreciation & Amortization | 410.58 Thousand | 342 Thousand | 243.34 Thousand | 113.95 Thousand | - | - |
| Deferred income taxes | - | -2.46 Million | -2.27 Million | -4.21 Million | - | - |
| Stock-based compensation | 874.03 Thousand | 1.91 Million | 1.87 Million | 3.92 Million | 115.41 Thousand | 716.76 Thousand |
| Change in working capital | -4.65 Million | 2.42 Million | 196.98 Thousand | -144.12 Thousand | 104.96 Thousand | 27.33 Thousand |
| Other non-cash items | 1.7 Million | 2.48 Million | 2.28 Million | 4.21 Million | 86.15 Thousand | 632.63 Thousand |
| Investing Cash Flow | -302.41 Thousand | -187.29 Thousand | -191.11 Thousand | -127.25 Thousand | - | -2.21 Million |
| Investments in PPE | -302.41 Thousand | -187.29 Thousand | -191.11 Thousand | -127.25 Thousand | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -187.31 Thousand | - | - | - | - | -2.21 Million |
| Financing Cash Flow | 15 Million | 2.52 Million | 1.08 Million | 8.9 Million | 4.28 Million | 5.58 Million |
| Debt repayment | -2177.00 | -2.75 Million | -175.1 Thousand | -97.66 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -5738.00 | - | - | - | - |
| Common Stock Issuance | 15.24 Million | -5738.00 | 1.25 Million | 8.99 Million | 4.28 Million | 5.58 Million |
| Other Financing Activities | -246.64 Thousand | 8.02 Million | -175.1 Thousand | 8.9 Million | 4.28 Million | 5.58 Million |
| Accounts receivables | -136.39 Thousand | 69.86 Thousand | 47.5 Thousand | - | 50.41 Thousand | - |
| Accounts payables | 227.51 Thousand | 64.12 Thousand | 41.04 Thousand | -53.2 Thousand | -21.15 Thousand | 84.13 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -4.74 Million | 2.29 Million | 108.43 Thousand | -90.91 Thousand | 75.7 Thousand | -56.8 Thousand |
| Cash at beginning of period | 9.96 Million | 6.79 Million | 9.68 Million | 5.4 Million | 4.38 Million | 1.01 Million |
| Cash at end of period | 18.6 Million | 9.96 Million | 6.79 Million | 9.68 Million | 5.4 Million | 4.38 Million |
| Capital Expenditure | -302.41 Thousand | -187.29 Thousand | -191.11 Thousand | -127.25 Thousand | - | - |
| Effect of forex changes on cash | - | - | 1.00 | - | - | 2.21 Million |
| Net cash flow / Change in cash | 8.63 Million | 3.16 Million | -2.89 Million | 4.28 Million | 1.02 Million | 3.36 Million |
| Free Cash Flow | -6.29 Million | 646.86 Thousand | -3.97 Million | -4.62 Million | -3.25 Million | -2.21 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.72 Million | -2.61 Million | -112.6 Thousand | -3.11 Million | -3.87 Million | -758.5 Thousand |
| Depreciation & Amortization | 410.58 Thousand | 207.81 Thousand | 202.76 Thousand | 189.49 Thousand | 342 Thousand | 152.51 Thousand |
| Deferred income taxes | - | - | - | -858.51 Thousand | -2.46 Million | - |
| Stock-based compensation | - | 165.02 Thousand | 709 Thousand | 409.66 Thousand | 1.91 Million | 1.5 Million |
| Change in working capital | -4.65 Million | -2.84 Million | - | 69.19 Thousand | 2.42 Million | - |
| Other non-cash items | 1.7 Million | 422.32 Thousand | -1 Million | 1.21 Million | 2.48 Million | 3.83 Million |
| Investing Cash Flow | -302.41 Thousand | -259.08 Thousand | -43.32 Thousand | -167.06 Thousand | -187.29 Thousand | -20.23 Thousand |
| Investments in PPE | -302.41 Thousand | -71.77 Thousand | -43.32 Thousand | -167.06 Thousand | -187.29 Thousand | -20.23 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -187.31 Thousand | - | - | - | - |
| Financing Cash Flow | 15 Million | 15.12 Million | -121.96 Thousand | 2.63 Million | 2.52 Million | -108.46 Thousand |
| Debt repayment | -2177.00 | -2177.00 | -120.83 Thousand | -2.75 Million | -2.75 Million | -107.08 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -5738.00 | -5738.00 | - |
| Common Stock Issuance | 15.24 Million | 15.24 Million | -1137.00 | 1375.00 | -5738.00 | -1375.00 |
| Other Financing Activities | - | 15.12 Million | -1137.00 | 2.63 Million | 8.02 Million | -1375.00 |
| Accounts receivables | -136.39 Thousand | -2.91 Million | - | 69.86 Thousand | 69.86 Thousand | - |
| Accounts payables | 227.51 Thousand | - | - | - | 64.12 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -4.74 Million | 70.25 Thousand | - | -671.00 | 2.29 Million | - |
| Cash at beginning of period | 9.96 Million | 8.48 Million | 9.96 Million | 9.58 Million | 6.79 Million | 6.79 Million |
| Cash at end of period | 18.6 Million | 18.6 Million | 8.48 Million | 9.96 Million | 9.96 Million | 9.58 Million |
| Capital Expenditure | -302.41 Thousand | -71.77 Thousand | -43.32 Thousand | -167.06 Thousand | -187.29 Thousand | -20.23 Thousand |
| Effect of forex changes on cash | - | - | 9.96 Million | -9.96 Million | - | 6.79 Million |
| Net cash flow / Change in cash | 8.63 Million | 10.12 Million | -1.48 Million | 379.59 Thousand | 3.16 Million | 2.79 Million |
| Free Cash Flow | -6.29 Million | -4.74 Million | -1.36 Million | -2.25 Million | 646.86 Thousand | 2.89 Million |
REZ
DECIPHER
AZNVF
BOTX
600218
2106